Benchling inks $34.5 mln Series C
San Francisco-based Benchling, a life sciences R&D cloud platform, has secured $34.5 million in Series C funding. Menlo Ventures led the round with participation from Lead Edge Capital, Y Combinator Continuity, Benchmark and Thrive Capital.
24 July 2019•1 min read
